Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$0.01 - $0.61 $67 - $4,141
6,789 Added 64.5%
17,314 $190,000
Q4 2023

Jan 30, 2024

SELL
$0.42 - $0.72 $8,949 - $15,341
-21,308 Reduced 66.94%
10,525 $6.6 Million
Q3 2023

Oct 30, 2023

BUY
$0.6 - $1.53 $18,928 - $48,268
31,548 Added 11069.47%
31,833 $19.4 Million
Q2 2023

Jul 27, 2023

BUY
$1.05 - $1.63 $59 - $92
57 Added 25.0%
285 $322,000
Q1 2023

Apr 20, 2023

BUY
$1.2 - $2.73 $70 - $161
59 Added 34.91%
228 $308,000
Q4 2022

Feb 02, 2023

BUY
$1.71 - $3.61 $288 - $610
169 New
169 $314,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Pay Pay Securities Corp Portfolio

Follow Pay Pay Securities Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pay Pay Securities Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pay Pay Securities Corp with notifications on news.